Induction of thymic lymphosarcoma and mammary adenocarcinomas in rats by oral administration of the antitumor agent4(5)-(3,3-dimethyl-l-triazeno)imidazole-5(4)-carboxamide
Open Access
- 1 November 1970
- Vol. 26 (5) , 1000-1005
- https://doi.org/10.1002/1097-0142(197011)26:5<1000::aid-cncr2820260506>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mechanism of carcinogenesis with 1-Aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitroBiochemical Pharmacology, 1969
- Teratogene Wirkung von 1-Phenyl-3,3-dimethyl-triazen, Erzeugung von Gaumenspalten bei BD-RattenCellular and Molecular Life Sciences, 1967
- Colorimetric determination of dialkyltriazenoimidazolesJournal of Pharmaceutical Sciences, 1967
- Carcinogenic Nitroso CompoundsAdvances in Cancer Research, 1967
- Neurotrope carcinogene Wirkung von Phenyl-dimethyl-triazen an RattenThe Science of Nature, 1967
- Leukemia in Germfree Rats.Experimental Biology and Medicine, 1966
- Imidazoles. II. 5(or 4)-(Monosubstituted Triazeno)imidazole-4(or 5)-carboxamides1Journal of Medicinal Chemistry, 1966
- Induction of leukemia in rat by pulse doses of 7,12-dimethylbenz(a)anthracene.Proceedings of the National Academy of Sciences, 1966
- Imidazoles. I. Coupling Reactions of 5-Diazoimidazole-4-carboxamide1,2The Journal of Organic Chemistry, 1962
- Induction of Leukemia in Rats with Mouse Leukemia (Passage A) Virus.Experimental Biology and Medicine, 1961